Sameeksha H. Tadepalli
Chandigarh, CH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Journal: Orbit (Amsterdam, Netherlands)
Published: February 22, 2022
Thyroid eye disease with concurrent orbital lymphoma: a radiological surprise.
Journal: Endocrinology, diabetes & metabolism case reports
Published: February 20, 2022
Iodine-125 Plaque Radiotherapy for Retinoblastoma Recurrence Following Intra-arterial Chemotherapy.
Journal: Journal of pediatric ophthalmology and strabismus
Published: December 20, 2021
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Journal: Indian journal of ophthalmology
Published: June 22, 2021
Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients.
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: January 22, 2021
Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Journal: Journal of pediatric ophthalmology and strabismus
Published: February 23, 2020
Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
Journal: The British journal of ophthalmology
Published: November 19, 2019
Ultra-Widefield Fundus Autofluorescence in Cytomegalovirus Retinitis.
Journal: Ocular immunology and inflammation
Published: May 29, 2019
Intraocular medulloepithelioma - A review of clinical features, DICER 1 mutation, and management.
Journal: Indian journal of ophthalmology
Published: May 25, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026